DK0833944T3 - Nucleinsyreligander som binder til og inhiberer DNA-polymeraser - Google Patents
Nucleinsyreligander som binder til og inhiberer DNA-polymeraserInfo
- Publication number
- DK0833944T3 DK0833944T3 DK96919197T DK96919197T DK0833944T3 DK 0833944 T3 DK0833944 T3 DK 0833944T3 DK 96919197 T DK96919197 T DK 96919197T DK 96919197 T DK96919197 T DK 96919197T DK 0833944 T3 DK0833944 T3 DK 0833944T3
- Authority
- DK
- Denmark
- Prior art keywords
- bind
- nucleic acid
- ligands
- dna polymerases
- acid ligands
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6844—Nucleic acid amplification reactions
- C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y207/00—Transferases transferring phosphorus-containing groups (2.7)
- C12Y207/07—Nucleotidyltransferases (2.7.7)
- C12Y207/07007—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/16—Aptamers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
- G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
- G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
- G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
- G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
- G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
- G01N2333/96433—Serine endopeptidases (3.4.21)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/81—Packaged device or kit
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Plant Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/484,557 US5693502A (en) | 1990-06-11 | 1995-06-07 | Nucleic acid ligand inhibitors to DNA polymerases |
US08/487,426 US5763173A (en) | 1990-06-11 | 1995-06-07 | Nucleic acid ligand inhibitors to DNA polymerases |
US08/487,720 US5874557A (en) | 1990-06-11 | 1995-06-07 | Nucleic acid ligand inhibitors to DNA polymerases |
PCT/US1996/009451 WO1996041010A1 (en) | 1995-06-07 | 1996-06-05 | Nucleic acid ligands that bind to and inhibit dna polymerases |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0833944T3 true DK0833944T3 (da) | 2009-05-11 |
Family
ID=27413687
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK09000032.4T DK2080813T3 (da) | 1995-06-07 | 1996-06-05 | Nukleinsyreligander, som binder til og inhiberer DNA-polymeraser |
DK96919197T DK0833944T3 (da) | 1995-06-07 | 1996-06-05 | Nucleinsyreligander som binder til og inhiberer DNA-polymeraser |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK09000032.4T DK2080813T3 (da) | 1995-06-07 | 1996-06-05 | Nukleinsyreligander, som binder til og inhiberer DNA-polymeraser |
Country Status (11)
Country | Link |
---|---|
US (1) | US6020130A (da) |
EP (2) | EP0833944B1 (da) |
JP (2) | JP4335975B2 (da) |
AT (2) | ATE494394T1 (da) |
AU (1) | AU726844B2 (da) |
CA (1) | CA2223078C (da) |
DE (2) | DE69638318D1 (da) |
DK (2) | DK2080813T3 (da) |
ES (1) | ES2321243T3 (da) |
PT (1) | PT833944E (da) |
WO (1) | WO1996041010A1 (da) |
Families Citing this family (107)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6395888B1 (en) * | 1996-02-01 | 2002-05-28 | Gilead Sciences, Inc. | High affinity nucleic acid ligands of complement system proteins |
US20060084797A1 (en) * | 1990-06-11 | 2006-04-20 | Gilead Sciences, Inc. | High affinity TGFbeta nucleic acid ligands and inhibitors |
DK0533838T3 (da) * | 1990-06-11 | 1998-02-23 | Nexstar Pharmaceuticals Inc | Nukleinsyreligander |
US20040132067A1 (en) * | 1990-06-11 | 2004-07-08 | Somalogic, Inc. | Systematic evolution of ligands by exponential enrichment: photoselection of nucleic acid ligands and solution selex |
US6458539B1 (en) * | 1993-09-17 | 2002-10-01 | Somalogic, Inc. | Photoselection of nucleic acid ligands |
US6183967B1 (en) * | 1995-06-07 | 2001-02-06 | Nexstar Pharmaceuticals | Nucleic acid ligand inhibitors to DNA polymerases |
US7070925B1 (en) | 1996-07-16 | 2006-07-04 | Gen-Probe Incorporated | Method for determining the presence of an RNA analyte in a sample using a modified oligonucleotide probe |
ES2270467T3 (es) | 1996-07-16 | 2007-04-01 | Gen-Probe Incorporated | Metodos para detectar y amplificar secuencias de acido nucleico utilizando oligonucleotidos modificados que tienen una tm especifica de la diana mas elevada. |
US6426335B1 (en) * | 1997-10-17 | 2002-07-30 | Gilead Sciences, Inc. | Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes |
WO2000006779A1 (en) * | 1998-07-31 | 2000-02-10 | Gen-Probe Incorporated | Reversible inhibiting probes |
EP1002875A1 (en) * | 1998-11-17 | 2000-05-24 | Mira Diagnostica GmbH | An oligonucleotide inhibitor of thermostable polymerase |
JP2002544496A (ja) * | 1999-05-12 | 2002-12-24 | プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ | 蛋白質プロセッティビティ因子相互作用の阻害剤をデザインするための構造ベースのアプローチ |
JP2002543795A (ja) * | 1999-05-12 | 2002-12-24 | インビトロゲン・コーポレーション | 核酸合成の感度および特異性の増大のための組成物および方法 |
WO2001002559A1 (en) * | 1999-07-02 | 2001-01-11 | Invitrogen Corporation | Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
US6830902B1 (en) * | 1999-07-02 | 2004-12-14 | Invitrogen Corporation | Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
US6214557B1 (en) * | 2000-06-06 | 2001-04-10 | Washington University | Cold sensitive mutant DNA polymerases |
US8568766B2 (en) * | 2000-08-24 | 2013-10-29 | Gattadahalli M. Anantharamaiah | Peptides and peptide mimetics to treat pathologies associated with eye disease |
AU9684601A (en) | 2000-10-12 | 2002-04-22 | Univ Rochester | Compositions that inhibit proliferation of cancer cells |
JP4773684B2 (ja) | 2001-05-25 | 2011-09-14 | デューク ユニバーシティ | 薬物のモジュレータ |
US6667165B2 (en) * | 2001-11-13 | 2003-12-23 | Eppendorf Ag | Method and compositions for reversible inhibition of thermostable polymerases |
KR20100094569A (ko) | 2002-02-06 | 2010-08-26 | 비코르 테크놀로지스 인코포레이티드 | 경색방지 분자 |
WO2003093452A2 (en) * | 2002-02-26 | 2003-11-13 | University Of Utah Research Foundation | Variants of nedd4l associated with hypertension and viral budding |
AU2003247576A1 (en) * | 2002-06-18 | 2003-12-31 | Archemix Corp. | Aptamer-toxin molecules and methods for using same |
US20040249130A1 (en) * | 2002-06-18 | 2004-12-09 | Martin Stanton | Aptamer-toxin molecules and methods for using same |
EP1543158B1 (en) * | 2002-07-25 | 2011-07-13 | Archemix Corp. | Regulated aptamer therapeutics |
US20050287648A1 (en) | 2002-08-05 | 2005-12-29 | University Of Rochester | Protein Transducing Domain/Deaminase Chimeric Proteins, Related Compounds, and Uses Thereof |
US9303262B2 (en) * | 2002-09-17 | 2016-04-05 | Archemix Llc | Methods for identifying aptamer regulators |
JP2006516151A (ja) * | 2002-11-21 | 2006-06-22 | アーケミックス コーポレイション | 改良された薬力学的特性を有する多価アプタマー治療剤ならびにそれらの作製方法および使用法 |
US10100316B2 (en) * | 2002-11-21 | 2018-10-16 | Archemix Llc | Aptamers comprising CPG motifs |
US20050124565A1 (en) * | 2002-11-21 | 2005-06-09 | Diener John L. | Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
US8853376B2 (en) | 2002-11-21 | 2014-10-07 | Archemix Llc | Stabilized aptamers to platelet derived growth factor and their use as oncology therapeutics |
US20050037394A1 (en) * | 2002-12-03 | 2005-02-17 | Keefe Anthony D. | Method for in vitro selection of 2'-substituted nucleic acids |
AU2003297682A1 (en) * | 2002-12-03 | 2004-06-23 | Archemix Corporation | Method for in vitro selection of 2'-substituted nucleic acids |
WO2004090153A2 (en) | 2003-04-01 | 2004-10-21 | Eragen Biosciences,Inc. | Polymerase inhibitor and method of using same |
WO2004094666A1 (en) * | 2003-04-24 | 2004-11-04 | Dzieglewska, Hanna | Allele-specific mutation detection assay |
US20050250106A1 (en) * | 2003-04-24 | 2005-11-10 | David Epstein | Gene knock-down by intracellular expression of aptamers |
US7727969B2 (en) * | 2003-06-06 | 2010-06-01 | Massachusetts Institute Of Technology | Controlled release nanoparticle having bound oligonucleotide for targeted delivery |
US20050112585A1 (en) * | 2003-11-21 | 2005-05-26 | Dominic Zichi | Method for adjusting the quantification range of individual analytes in a multiplexed assay |
US7803931B2 (en) | 2004-02-12 | 2010-09-28 | Archemix Corp. | Aptamer therapeutics useful in the treatment of complement-related disorders |
ES2429442T3 (es) * | 2004-02-12 | 2013-11-14 | Archemix Llc | Aptámeros terapéuticos útiles en el tratamiento de trastornos relacionados con complemento |
US20060193821A1 (en) * | 2004-03-05 | 2006-08-31 | Diener John L | Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeutics |
WO2005086835A2 (en) * | 2004-03-05 | 2005-09-22 | Archemix Corp. | Aptamers to the human il-12 cytokine family and their use as autoimmune disease therapeutics |
US20080214489A1 (en) * | 2004-04-19 | 2008-09-04 | Anthony Dominic Keefe | Aptamer-mediated intracellular delivery of oligonucleotides |
US7579450B2 (en) * | 2004-04-26 | 2009-08-25 | Archemix Corp. | Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeutics |
US7566701B2 (en) * | 2004-09-07 | 2009-07-28 | Archemix Corp. | Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics |
AU2005287273B2 (en) | 2004-09-07 | 2011-05-12 | Archemix Corp. | Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics |
EP1791557A4 (en) * | 2004-09-07 | 2009-09-23 | Archemix Corp | MEDICAL CHEMISTRY USING APTAMERS |
US7517977B2 (en) * | 2004-10-18 | 2009-04-14 | Brandeis University | Reagents and methods for improving reproducibility and reducing mispriming in PCR amplification |
WO2006074233A2 (en) | 2005-01-06 | 2006-07-13 | Applera Corporation | Polypeptides having nucleic acid binding activity and compositions and methods for nucleic acid amplification |
WO2006099875A1 (en) | 2005-03-23 | 2006-09-28 | Genmab A/S | Antibodies against cd38 for treatment of multiple myeloma |
US7476733B2 (en) * | 2005-03-25 | 2009-01-13 | The United States Of America As Represented By The Department Of Health And Human Services | Development of a real-time PCR assay for detection of pneumococcal DNA and diagnosis of pneumococccal disease |
US20090075342A1 (en) * | 2005-04-26 | 2009-03-19 | Sharon Cload | Metabolic profile directed aptamer medicinal chemistry |
US20070059713A1 (en) | 2005-09-09 | 2007-03-15 | Lee Jun E | SSB-DNA polymerase fusion proteins |
JP5438320B2 (ja) * | 2005-10-03 | 2014-03-12 | アプライド バイオシステムズ リミテッド ライアビリティー カンパニー | 核酸を増幅するための組成物、方法およびキット |
WO2007044607A2 (en) * | 2005-10-06 | 2007-04-19 | Emthrax, Llc | Methods and compositions relating to anthrax spore glycoproteins as vaccines |
US8080534B2 (en) | 2005-10-14 | 2011-12-20 | Phigenix, Inc | Targeting PAX2 for the treatment of breast cancer |
EP2392647A1 (en) | 2005-10-14 | 2011-12-07 | MUSC Foundation For Research Development | Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy |
JP5022383B2 (ja) * | 2006-02-27 | 2012-09-12 | エフ.ホフマン−ラ ロシュ アーゲー | マグネシウム封鎖によるpcrホットスタート |
PL1991275T3 (pl) * | 2006-03-08 | 2015-04-30 | Archemix Llc | Aptamery wiążące dopełniacza i środki anty-C5 użyteczne w leczeniu zaburzeń ocznych |
RU2394915C2 (ru) * | 2006-03-24 | 2010-07-20 | Александр Борисович Четверин | Бесконтактные способы обнаружения молекулярных колоний, наборы реагентов и устройство для их осуществления |
DE102006015960A1 (de) | 2006-04-04 | 2007-10-11 | Qiagen Gmbh | Gemisch reversibel inhibierter Enzyme |
US7786294B2 (en) * | 2006-06-08 | 2010-08-31 | Saint Louis University | Compositions and methods for amplification and cloning of near full-length viral genome samples |
EP2049689B1 (en) * | 2006-07-31 | 2011-12-21 | Wanli Bi | Nucleic acid amplification using a reversibly modified oligonucleotide |
US9045522B2 (en) | 2006-07-31 | 2015-06-02 | Wanli Bi | Nucleic acid amplification using a reversibly modified oligonucleotide |
US20100190689A1 (en) | 2006-09-21 | 2010-07-29 | University Of Rochester | Compositions and methods related to protein displacement therapy for myotonic distrophy |
EP2104516B1 (en) | 2006-11-01 | 2015-01-07 | University of Rochester | Methods and compositions related to the structure and function of apobec3g |
BRPI0720038A2 (pt) | 2006-12-11 | 2013-12-24 | Univ Utah Res Found | Métodos para inibir a permeabilidade vascular em tecido, para triar ou avaliar um agente que inibe a permeabilidade vascular, para tratar ou prevenir a síndrome da angústia respiratória, a retinopatia de prematuridade, a retinopatia diabética e a degeneração macular úmida em um indivíduo, para tratar indivíduos com sugestões repulsivas ou miméticos e para promover a angiogênese em um tecido, polipeptídeo isolado, ácido nucleico isolado, e, vetor |
WO2008150495A2 (en) * | 2007-06-01 | 2008-12-11 | Archemix Corp. | Vwf aptamer formulations and methods for use |
KR101634608B1 (ko) | 2007-07-17 | 2016-06-29 | 소마로직, 인크. | 개선된 오프―레이트를 갖는 압타머를 생성하는 방법 |
CA2697957A1 (en) | 2007-08-28 | 2009-03-12 | Uab Research Foundation | Synthetic apolipoprotein e mimicking polypeptides and methods of use |
US9422363B2 (en) * | 2007-08-28 | 2016-08-23 | Uab Research Foundation | Synthetic apolipoprotein E mimicking polypeptides and methods of use |
EP2268664B1 (en) * | 2007-12-03 | 2017-05-24 | The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services | Doc1 compositions and methods for treating cancer |
US20090233993A1 (en) * | 2008-03-06 | 2009-09-17 | Burnham Institute For Medical Research | Compositions and methods for inhibiting gsk3 activity and uses thereof |
CA2658520C (en) | 2008-03-19 | 2016-11-08 | F. Hoffmann-La Roche Ag | Nucleic acid amplification in the presence of modified randomers |
EP2288922B1 (en) | 2008-05-08 | 2016-08-17 | University of Utah Research Foundation | Sensory receptors for chronic fatigue and pain and uses thereof |
WO2010019963A2 (en) * | 2008-08-15 | 2010-02-18 | Georgetown University | Na channels, disease, and related assays and compositions |
US7910720B2 (en) * | 2008-09-09 | 2011-03-22 | Roche Diagnostics Operations, Inc. | Polyanion for improved nucleic acid amplification |
WO2010065617A1 (en) | 2008-12-02 | 2010-06-10 | University Of Utah Research Foundation | Pde1 as a target therapeutic in heart disease |
EP2373804B1 (en) * | 2008-12-05 | 2014-11-12 | DNA Polymerase Technology, Inc. | Compositions for improving gene amplification |
EP2406394B1 (en) | 2009-03-12 | 2014-01-08 | Brandeis University | Reagents and methods for pcr |
WO2011031974A1 (en) | 2009-09-10 | 2011-03-17 | Southern Research Institute | Acridine analogs in the treatment of gliomas |
US8841429B2 (en) * | 2009-11-03 | 2014-09-23 | Vivonics, Inc. | Nucleic acid ligands against infectious prions |
US8236570B2 (en) * | 2009-11-03 | 2012-08-07 | Infoscitex | Methods for identifying nucleic acid ligands |
US20110207789A1 (en) | 2010-02-19 | 2011-08-25 | Ye Fang | Methods related to casein kinase ii (ck2) inhibitors and the use of purinosome-disrupting ck2 inhibitors for anti-cancer therapy agents |
US20110250598A1 (en) | 2010-04-12 | 2011-10-13 | Ulrike Fischer | Detergent free polymerases |
EP2606149B1 (en) | 2010-08-20 | 2017-08-02 | Life Technologies Corporation | Polymerase assay with a fret substrate |
CN103562408A (zh) | 2011-03-15 | 2014-02-05 | 犹他大学研究基金会 | 诊断和治疗血管相关黄斑病及其症状的方法 |
JP5830286B2 (ja) * | 2011-07-12 | 2015-12-09 | アークレイ株式会社 | 核酸の増幅検出方法およびキット |
JP5977000B2 (ja) * | 2011-07-12 | 2016-08-24 | アークレイ株式会社 | 核酸の増幅検出方法およびキット |
AU2012325697B2 (en) | 2011-10-21 | 2015-11-26 | Decimadx, Llc | Point-of care immunoassay for quantitative small analyte detection |
PT2855692T (pt) | 2012-05-24 | 2019-10-25 | Univ Utah Res Found | Pcr extrema. |
CN104487596B (zh) | 2012-06-14 | 2020-03-13 | 生命技术公司 | 用于聚合酶链式反应(pcr)的新型组合物、方法和试剂盒 |
US9212392B2 (en) | 2012-09-25 | 2015-12-15 | Exact Sciences Corporation | Normalization of polymerase activity |
CA2904970C (en) | 2013-03-12 | 2022-07-05 | University Of Utah Research Foundation | Compositions and methods for inducing apoptosis |
CN103966184A (zh) * | 2014-05-06 | 2014-08-06 | 江西省科学院微生物研究所 | 一种实时热启动Taq酶及其制备方法 |
CN107074923B (zh) | 2014-07-31 | 2021-08-03 | Uab研究基金会 | Apoe模拟肽及对清除血浆胆固醇的较高效力 |
CN108367287B (zh) | 2015-11-05 | 2021-04-02 | 犹他州大学研究基金会 | 极端逆转录pcr |
CN108602849B (zh) | 2016-04-06 | 2022-10-21 | 俄亥俄州国家创新基金会 | 用于通过rna纳米技术将治疗剂特异性递送至细胞的rna配体展示外来体 |
US10925973B2 (en) | 2016-06-15 | 2021-02-23 | University Of Utah Research Foundation | Compositions and methods for using albumin-based nanomedicines |
EP3496736A4 (en) | 2016-08-03 | 2020-05-13 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | THERAPEUTICS AGAINST TLR9 |
US11408885B2 (en) | 2017-08-31 | 2022-08-09 | Massachusetts Institute Of Technology | Compositions and multiplex assays for characterizing active proteases and their inhibitors |
US12016314B2 (en) | 2017-09-08 | 2024-06-25 | Ohio State Innovation Foundation | MicroRNA inhibitor therapy in systemic lupus erythematosus |
EP3691693A4 (en) | 2017-10-06 | 2021-08-25 | University Of Utah Research Foundation | FUSION PROTEIN FOR TARGETED THERAPY OF AUTOIMMUNE DISEASE |
CN107619430B (zh) * | 2017-10-17 | 2021-01-15 | 江西省科学院微生物研究所 | 一种热稳定的Taq酶温控亲和性配体及其制备方法、应用 |
GB201812192D0 (en) | 2018-07-26 | 2018-09-12 | Ttp Plc | Variable temperature reactor, heater and control circuit for the same |
US20220056068A1 (en) | 2018-09-21 | 2022-02-24 | King Abdullah University Of Science And Technology | Ligand detection by aptamers with a built-in reporter |
CN115135664A (zh) | 2020-06-22 | 2022-09-30 | 苏州新海生物科技股份有限公司 | 一种核酸配体及其应用 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS562226A (en) | 1979-06-13 | 1981-01-10 | Nissan Motor Co Ltd | Dozing drive detector |
GB2183661B (en) * | 1985-03-30 | 1989-06-28 | Marc Ballivet | Method for obtaining dna, rna, peptides, polypeptides or proteins by means of a dna recombinant technique |
US5354657A (en) * | 1988-01-12 | 1994-10-11 | Boehringer Mannheim Gmbh | Process for the highly specific detection of nucleic acids in solid |
WO1989006694A1 (en) * | 1988-01-15 | 1989-07-27 | Trustees Of The University Of Pennsylvania | Process for selection of proteinaceous substances which mimic growth-inducing molecules |
US5348010A (en) | 1989-02-24 | 1994-09-20 | Medrea, Inc., Pennsylvania Corp., Pa. | Intracavity probe and interface device for MRI imaging and spectroscopy |
US5472841A (en) * | 1990-06-11 | 1995-12-05 | Nexstar Pharmaceuticals, Inc. | Methods for identifying nucleic acid ligands of human neutrophil elastase |
US5476766A (en) * | 1990-06-11 | 1995-12-19 | Nexstar Pharmaceuticals, Inc. | Ligands of thrombin |
US5496938A (en) | 1990-06-11 | 1996-03-05 | Nexstar Pharmaceuticals, Inc. | Nucleic acid ligands to HIV-RT and HIV-1 rev |
US5567588A (en) * | 1990-06-11 | 1996-10-22 | University Research Corporation | Systematic evolution of ligands by exponential enrichment: Solution SELEX |
US5270163A (en) * | 1990-06-11 | 1993-12-14 | University Research Corporation | Methods for identifying nucleic acid ligands |
US5637459A (en) | 1990-06-11 | 1997-06-10 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chimeric selex |
US5705337A (en) | 1990-06-11 | 1998-01-06 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: chemi-SELEX |
US5543293A (en) * | 1990-06-11 | 1996-08-06 | Nexstar Pharmaceuticals, Inc. | DNA ligands of thrombin |
US5503978A (en) * | 1990-06-11 | 1996-04-02 | University Research Corporation | Method for identification of high affinity DNA ligands of HIV-1 reverse transcriptase |
US5527894A (en) * | 1990-06-11 | 1996-06-18 | Nexstar Pharmacueticals, Inc. | Ligands of HIV-1 tat protein |
DK0533838T3 (da) * | 1990-06-11 | 1998-02-23 | Nexstar Pharmaceuticals Inc | Nukleinsyreligander |
US5580737A (en) * | 1990-06-11 | 1996-12-03 | Nexstar Pharmaceuticals, Inc. | High-affinity nucleic acid ligands that discriminate between theophylline and caffeine |
US5587468A (en) * | 1990-06-11 | 1996-12-24 | University Research Corporation | High affinity nucleic acid ligands to HIV integrase |
US5459015A (en) * | 1990-06-11 | 1995-10-17 | Nexstar Pharmaceuticals, Inc. | High-affinity RNA ligands of basic fibroblast growth factor |
US5683867A (en) | 1990-06-11 | 1997-11-04 | Nexstar Pharmaceuticals, Inc. | Systematic evolution of ligands by exponential enrichment: blended SELEX |
CA2104698A1 (en) * | 1991-02-21 | 1992-08-22 | John J. Toole | Aptamers specific for biomolecules and methods of making |
US5338671A (en) * | 1992-10-07 | 1994-08-16 | Eastman Kodak Company | DNA amplification with thermostable DNA polymerase and polymerase inhibiting antibody |
US5567604A (en) * | 1993-04-23 | 1996-10-22 | Aronex Pharmaceuticals, Inc. | Anti-viral guanosine-rich oligonucleotides |
US20170110787A1 (en) | 2015-10-14 | 2017-04-20 | Apple Inc. | Electronic Devices With Millimeter Wave Antennas And Metal Housings |
-
1996
- 1996-06-05 EP EP96919197A patent/EP0833944B1/en not_active Expired - Lifetime
- 1996-06-05 DK DK09000032.4T patent/DK2080813T3/da active
- 1996-06-05 AT AT09000032T patent/ATE494394T1/de active
- 1996-06-05 DE DE69638318T patent/DE69638318D1/de not_active Expired - Lifetime
- 1996-06-05 ES ES96919197T patent/ES2321243T3/es not_active Expired - Lifetime
- 1996-06-05 US US08/945,734 patent/US6020130A/en not_active Expired - Fee Related
- 1996-06-05 AT AT96919197T patent/ATE420202T1/de active
- 1996-06-05 DE DE69637805T patent/DE69637805D1/de not_active Expired - Lifetime
- 1996-06-05 PT PT96919197T patent/PT833944E/pt unknown
- 1996-06-05 CA CA002223078A patent/CA2223078C/en not_active Expired - Lifetime
- 1996-06-05 AU AU61598/96A patent/AU726844B2/en not_active Expired
- 1996-06-05 WO PCT/US1996/009451 patent/WO1996041010A1/en active Application Filing
- 1996-06-05 EP EP09000032A patent/EP2080813B1/en not_active Expired - Lifetime
- 1996-06-05 DK DK96919197T patent/DK0833944T3/da active
- 1996-06-05 JP JP50176797A patent/JP4335975B2/ja not_active Expired - Lifetime
-
2008
- 2008-09-10 JP JP2008263257A patent/JP2009106277A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP2080813B1 (en) | 2011-01-05 |
DE69638318D1 (de) | 2011-02-17 |
DK2080813T3 (da) | 2011-03-28 |
AU6159896A (en) | 1996-12-30 |
EP0833944A4 (en) | 1999-12-01 |
WO1996041010A1 (en) | 1996-12-19 |
EP2080813A1 (en) | 2009-07-22 |
JP2009106277A (ja) | 2009-05-21 |
ES2321243T3 (es) | 2009-06-03 |
JP4335975B2 (ja) | 2009-09-30 |
JPH11507223A (ja) | 1999-06-29 |
EP0833944B1 (en) | 2009-01-07 |
CA2223078A1 (en) | 1996-12-19 |
PT833944E (pt) | 2009-04-14 |
ATE420202T1 (de) | 2009-01-15 |
EP0833944A1 (en) | 1998-04-08 |
CA2223078C (en) | 2008-11-25 |
US6020130A (en) | 2000-02-01 |
DE69637805D1 (de) | 2009-02-26 |
AU726844B2 (en) | 2000-11-23 |
ATE494394T1 (de) | 2011-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0833944T3 (da) | Nucleinsyreligander som binder til og inhiberer DNA-polymeraser | |
DK1171632T3 (da) | Nucleinsyreligand-inhibitorer af DNA-polymeraser | |
ATE266737T1 (de) | Künstliche fehlhybridisierung | |
EP2272952B8 (en) | Thermostable or thermoactive DNA polymerase with attenuated 3'-5' exonuclease activity | |
AU6672601A (en) | Cold sensitive mutant dna polymerases | |
ATE232242T1 (de) | Universale primersequenz zur multiplex dna amplifikation | |
BR0014182A (pt) | Processos e composições para amplificação isotérmica linear de sequências polinucleotìdicas | |
EP1130118A3 (en) | Amplification of long nucleic acid sequences by PCR | |
AU3064200A (en) | A method of dna sequencing | |
ATE277068T1 (de) | 2'-modifizierte oligonucleotide mit rns wirkung, die konformell eingeschränkt sind | |
ATE427361T1 (de) | Verfahren zur dna-amplifikation und - sequenzierung | |
WO2004022770A3 (en) | Compositions and methods for synthesizing nucleic acids | |
ATE476523T1 (de) | Verfahren zur genomamplifikation | |
DK0707659T3 (da) | Identifikation af Salmonella ved hjælp af polymerasekædereaktion | |
ATE361377T1 (de) | Leistungstarke verknüpfung von nukleinsäuresegmenten | |
WO1996006949A3 (en) | Nucleic acid hybridization assay probes targeted to mycoplasma pneumoniae nucleic acid | |
WO2001009347A3 (en) | Archaeal replication accessory factors and methods of use | |
WO2001064838A3 (en) | Thermophilic dna polymerases from thermoactinomyces vulgaris | |
JP2004516801A5 (da) | ||
WO2000065098A3 (en) | Nucleotide extension on a microarray of gel-immobilized primers | |
Chenchik et al. | Method for suppressing dna fragment amplification during pcr | |
EP1233073A3 (en) | Oligonucleotide for detecting salmonella and method of detecting salmonella | |
Stemmer | Enzymatic inverse polymerase chain reaction | |
EP1405920A3 (en) | Improved FRET process | |
WO2002050094A3 (en) | Nucleic acid synthesis by primer extension on successive templates |